Cordx 4 in 1 lay-antigen combination test RSV viruses + corona Covid-19 + influenza A + B | Pack (1 test)

Combined test for the qualitative in-vitro detection for SARS-COV-2, Influenza A/B Virus and RSV antigens

Details

The Cordx® 4in1 combination test, suitable for in Vitro Diagnostics and only for self -tests, enables the simultaneous qualitative evidence and the differentiation of new Coronaviruses (Sars Cov 2 Antigene), Influenza a Virus Antigen, Influenza B Virus Antigen and/or RSV Antigen in Nose smear samples. This kit can be used as a diagnostic assistant for the Coronavirus infectious disease (COVID-19) caused by SARS COV2 in symptomatic patients within the first 7 days after the start of symptoms. It also serves the diagnosis of diseases caused by influenza A/B viruses or RSV.

• 4 in 1 lay-antigen combination test
• Combine test for the qualitative detection of SARS-COV-2, Influenza A+B and RS viruses
• Request in the front nose area
• Also recognizes the latest virus variants Eris and Pirola
• Prefilled buffer solution
• Release for self -application by laypersons
• CE certified / approved across Europe CE 2934
• 1 test per pack

Sensitivity and listings

• Influenza A: Sensitivity 100.00%, specificity 99.34%
• Influenza B: Sensitivity 96.00%, specificity 99.60%
• SARS-COV-2: Sensitivity 89.09%, specificity 100.00%
• RSV: Sensitivity 98.98% specificity 99.21%
• CE 2934 certified

scope of delivery

• 1x 4in1 test cassette
• 1x extraction tube with integrated buffer solution
• 1x sterile swab
• 1x multilingual instructions for use

For more information, please refer to the data sheets.